Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
$185M |
| 3 |
WESCO International
WCC
|
$171M |
| 4 |
Gilead Sciences
GILD
|
$158M |
| 5 |
Delta Air Lines
DAL
|
$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$221M |
| 2 |
3M
MMM
|
$154M |
| 3 |
Marsh & McLennan
MMC
|
$115M |
| 4 |
Johnson & Johnson
JNJ
|
$99M |
| 5 |
Novo Nordisk
NVO
|
$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Veru
VERU
$49.4M
| $1.5M | ﹤0.01% |
230,000
-556,111
| -71% | -$3.62M |
|
802
Moog
MOG.A
$6.17B
| $1.49M | ﹤0.01% |
7,553
| – | – |
|
803
Werner Enterprises
WERN
$1.71B
| $1.46M | ﹤0.01% |
40,545
| – | – |
|
|
SLRN
804
DELISTED
ACELYRIN
SLRN
| $1.41M | ﹤0.01% |
450,000
-95,476
| -18% | -$300K |
|
805
Immunic
IMUX
$75.1M
| $1.4M | ﹤0.01% |
1,398,600
-4,195,806
| -75% | -$4.2M |
|
806
Arcutis Biotherapeutics
ARQT
$2.06B
| $1.39M | ﹤0.01% |
+100,000
| New | +$1.39M |
|
807
Civitas Resources
CIVI
$3.19B
| $1.38M | ﹤0.01% |
30,000
-145,000
| -83% | -$6.65M |
|
|
ORKA
808
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
| $1.34M | ﹤0.01% |
69,200
-130,800
| -65% | -$2.54M |
|
|
IMA
809
ImageneBio, Inc. Common Stock
IMA
$89M
| $1.31M | ﹤0.01% |
66,667
-15,658
| -19% | -$308K |
|
|
CBIO
810
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $1.27M | ﹤0.01% |
+50,912
| New | +$1.27M |
|
811
Old Second Bancorp
OSBC
$970M
| $1.24M | ﹤0.01% |
+69,987
| New | +$1.24M |
|
812
Lifestance Health
LFST
$2.09B
| $1.18M | ﹤0.01% |
160,000
| – | – |
|
813
MidWestOne Financial Group
MOFG
$618M
| $1.14M | ﹤0.01% |
39,085
-110,915
| -74% | -$3.23M |
|
814
Match Group
MTCH
$9.18B
| $1.13M | ﹤0.01% |
34,616
-58,500
| -63% | -$1.91M |
|
815
Option Care Health
OPCH
$4.72B
| $1.07M | ﹤0.01% |
46,000
-15,000
| -25% | -$348K |
|
816
Community Trust Bancorp
CTBI
$1.06B
| $1.06M | ﹤0.01% |
+20,000
| New | +$1.06M |
|
817
Palladyne AI
PDYN
$286M
| $1.02M | ﹤0.01% |
83,333
| – | – |
|
818
Liquidia Corp
LQDA
$2.48B
| $992K | ﹤0.01% |
+84,376
| New | +$992K |
|
819
Instil Bio
TIL
$213M
| $955K | ﹤0.01% |
+50,000
| New | +$955K |
|
820
Selective Insurance
SIGI
$4.86B
| $935K | ﹤0.01% |
+10,000
| New | +$935K |
|
821
Ovid Therapeutics
OVID
$87.5M
| $934K | ﹤0.01% |
+1,000,000
| New | +$934K |
|
822
Surrozen
SRZN
$105M
| $928K | ﹤0.01% |
+64,653
| New | +$928K |
|
823
Lifezone Metals Limited Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
LZM.WS
| $907K | ﹤0.01% |
1,231,797
| – | – |
|
|
QXO
824
QXO Inc
QXO
$14.9B
| $797K | ﹤0.01% |
50,148
| – | – |
|
825
HealthEquity
HQY
$7.88B
| $768K | ﹤0.01% |
+8,000
| New | +$768K |
|